Limits...
The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism.

Ravel-Chapuis A, Crawford TE, Blais-Crépeau ML, Bélanger G, Richer CT, Jasmin BJ - Mol. Biol. Cell (2014)

Bottom Line: Cells overexpressing Staufen1 differentiated poorly, as evidenced by reductions in the differentiation and fusion indices and decreases in MyoD, myogenin, MEF2A, and MEF2C, independently of Staufen-mediated mRNA decay.By contrast, the knockdown of Staufen1 decreased c-myc levels in myoblasts.Collectively our results show that Staufen1 is highly expressed during early stages of differentiation/development and that it can impair differentiation by regulating c-myc, thereby highlighting the multifunctional role of Staufen1 in skeletal muscle cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.

Show MeSH

Related in: MedlinePlus

Staufen1 decreases in developing wild-type muscle. (A) Representative Western blots showing Staufen1, CUGBP1, β-actin, and GAPDH protein levels during skeletal muscle development. Samples were from embryos (E14.5 and E18.5), new-born mice (PN1), and adult mice (14 wk). Ponceau staining was used to show equal loading. (B, C) Relative quantification of Staufen1 and CUGBP1 protein levels, respectively (n = 3). Asterisks indicate significance (**p ≤ 0.01, ***p ≤ 0.001).
© Copyright Policy - creative-commons
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4230783&req=5

Figure 1: Staufen1 decreases in developing wild-type muscle. (A) Representative Western blots showing Staufen1, CUGBP1, β-actin, and GAPDH protein levels during skeletal muscle development. Samples were from embryos (E14.5 and E18.5), new-born mice (PN1), and adult mice (14 wk). Ponceau staining was used to show equal loading. (B, C) Relative quantification of Staufen1 and CUGBP1 protein levels, respectively (n = 3). Asterisks indicate significance (**p ≤ 0.01, ***p ≤ 0.001).

Mentions: As a control, we first examined expression of CUGBP1, a developmentally regulated RNA-binding protein in skeletal muscle (Ladd et al., 2001, 2005; Lin et al., 2006). We show that its expression is significantly decreased during skeletal muscle development (p < 0.001), recapitulating expression profiles previously observed (Figure 1, A and B). Then we analyzed Staufen1 levels and showed that Staufen1 is highly abundant in embryonic muscle limbs at E14.5 (Figure 1, A and C). However, expression of Staufen1 decreases gradually (p < 0.001) throughout skeletal muscle mass development, resulting in a low level of expression in mature adult muscle. Because the whole muscle mass was used in these experiments, we cannot exclude that Staufen1 is decreased in several cell types contained within developing muscle tissues. By contrast, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin were used as loading controls and show increased expression during muscle mass development (Figure 1A). Together these results suggest that expression of the RNA-binding protein Staufen1 is developmentally regulated during mouse skeletal muscle development.


The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc-dependent mechanism.

Ravel-Chapuis A, Crawford TE, Blais-Crépeau ML, Bélanger G, Richer CT, Jasmin BJ - Mol. Biol. Cell (2014)

Staufen1 decreases in developing wild-type muscle. (A) Representative Western blots showing Staufen1, CUGBP1, β-actin, and GAPDH protein levels during skeletal muscle development. Samples were from embryos (E14.5 and E18.5), new-born mice (PN1), and adult mice (14 wk). Ponceau staining was used to show equal loading. (B, C) Relative quantification of Staufen1 and CUGBP1 protein levels, respectively (n = 3). Asterisks indicate significance (**p ≤ 0.01, ***p ≤ 0.001).
© Copyright Policy - creative-commons
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4230783&req=5

Figure 1: Staufen1 decreases in developing wild-type muscle. (A) Representative Western blots showing Staufen1, CUGBP1, β-actin, and GAPDH protein levels during skeletal muscle development. Samples were from embryos (E14.5 and E18.5), new-born mice (PN1), and adult mice (14 wk). Ponceau staining was used to show equal loading. (B, C) Relative quantification of Staufen1 and CUGBP1 protein levels, respectively (n = 3). Asterisks indicate significance (**p ≤ 0.01, ***p ≤ 0.001).
Mentions: As a control, we first examined expression of CUGBP1, a developmentally regulated RNA-binding protein in skeletal muscle (Ladd et al., 2001, 2005; Lin et al., 2006). We show that its expression is significantly decreased during skeletal muscle development (p < 0.001), recapitulating expression profiles previously observed (Figure 1, A and B). Then we analyzed Staufen1 levels and showed that Staufen1 is highly abundant in embryonic muscle limbs at E14.5 (Figure 1, A and C). However, expression of Staufen1 decreases gradually (p < 0.001) throughout skeletal muscle mass development, resulting in a low level of expression in mature adult muscle. Because the whole muscle mass was used in these experiments, we cannot exclude that Staufen1 is decreased in several cell types contained within developing muscle tissues. By contrast, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin were used as loading controls and show increased expression during muscle mass development (Figure 1A). Together these results suggest that expression of the RNA-binding protein Staufen1 is developmentally regulated during mouse skeletal muscle development.

Bottom Line: Cells overexpressing Staufen1 differentiated poorly, as evidenced by reductions in the differentiation and fusion indices and decreases in MyoD, myogenin, MEF2A, and MEF2C, independently of Staufen-mediated mRNA decay.By contrast, the knockdown of Staufen1 decreased c-myc levels in myoblasts.Collectively our results show that Staufen1 is highly expressed during early stages of differentiation/development and that it can impair differentiation by regulating c-myc, thereby highlighting the multifunctional role of Staufen1 in skeletal muscle cells.

View Article: PubMed Central - PubMed

Affiliation: Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.

Show MeSH
Related in: MedlinePlus